Table 2 The results of univariate analysis
LDL-C | β (95% CI) | P value |
|---|---|---|
Sex | ||
Male | ref | |
Female | -0.14 (-0.46, 0.18) | 0.3987 |
Age (years) | 0.01 (-0.00, 0.02) | 0.1842 |
BMI (kg/m2) | 0.02 (-0.02, 0.07) | 0.3270 |
Statin use | ||
No | 0 | |
Yes | 0.01 (-0.32, 0.33) | 0.9622 |
Smoke | ||
No | 0 | |
Yes | 0.09 (-0.26, 0.44) | 0.6116 |
AMI | ||
No | 0 | |
Yes | 0.53 (0.10, 0.97) | 0.0184 |
TG (mmol/L) | 0.21 (0.10, 0.33) | 0.0003 |
TC (mmol/L) | 0.78 (0.73, 0.83) | < 0.0001 |
HDL-C (mmol/L) | 0.23 (-0.36, 0.81) | 0.4511 |
RC (mmol/L) | 0.76 (0.33, 1.19) | 0.0007 |
Lp (a) (mg/L) | 0.00 (-0.00, 0.00) | 0.1280 |
NEFA (mmol/L) | 0.95 (0.23, 1.67) | 0.0113 |
APO-A1 (g/L) | 0.70 (-0.41, 1.81) | 0.2167 |
APO-B (g/L) | 3.47 (3.25, 3.68) | < 0.0001 |
WBCC (109/L) | 0.10 (0.01, 0.19) | 0.0319 |
CAD | ||
No | 0 | |
Yes | 0.36 (0.03, 0.69) | 0.0340 |
T2DM | ||
No | 0 | |
Yes | 0.27 (-0.10, 0.65) | 0.1574 |
Hypertension | ||
No | 0 | |
Yes | 0.17 (-0.16, 0.49) | 0.3183 |
sASGR1 (ng/mL) | 0.10 (0.06, 0.14) | < 0.0001 |